NO981051L - Peptidderivater - Google Patents
PeptidderivaterInfo
- Publication number
- NO981051L NO981051L NO981051A NO981051A NO981051L NO 981051 L NO981051 L NO 981051L NO 981051 A NO981051 A NO 981051A NO 981051 A NO981051 A NO 981051A NO 981051 L NO981051 L NO 981051L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen atoms
- alkyl
- compounds
- hydrogen
- tyr
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 206010058019 Cancer Pain Diseases 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- VDIPNVCWMXZNFY-UHFFFAOYSA-N N-methyl-beta-alanine Chemical compound CNCCC(O)=O VDIPNVCWMXZNFY-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229940124280 l-arginine Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23216195 | 1995-09-11 | ||
| PCT/JP1996/002572 WO1997010261A1 (fr) | 1995-09-11 | 1996-09-10 | Derives peptidiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO981051D0 NO981051D0 (no) | 1998-03-10 |
| NO981051L true NO981051L (no) | 1998-05-11 |
Family
ID=16934959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO981051A NO981051L (no) | 1995-09-11 | 1998-03-10 | Peptidderivater |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6228841B1 (fr) |
| EP (1) | EP0861849A4 (fr) |
| KR (1) | KR19990044553A (fr) |
| CN (1) | CN1200736A (fr) |
| AU (1) | AU718192B2 (fr) |
| BR (1) | BR9610086A (fr) |
| CA (1) | CA2231174A1 (fr) |
| EA (1) | EA001000B1 (fr) |
| NO (1) | NO981051L (fr) |
| WO (1) | WO1997010261A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999033864A1 (fr) * | 1997-12-26 | 1999-07-08 | Daiichi Pharmaceutical Co., Ltd. | Derives peptidiques |
| WO2000012539A1 (fr) * | 1998-08-31 | 2000-03-09 | Fuji Chemical Industries, Ltd. | Composes de peptides |
| WO2001013938A1 (fr) * | 1999-08-25 | 2001-03-01 | Daiichi Fine Chemical Co., Ltd. | Composition therapeutique pouvant etre administree par voie percutanee ou par les muqueuses |
| WO2007145208A1 (fr) | 2006-06-12 | 2007-12-21 | Vexon, Inc. | Dérivé peptidique |
| WO2007144979A1 (fr) * | 2006-06-12 | 2007-12-21 | Vexon, Inc. | Dérivé de peptide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6136298A (ja) * | 1984-07-27 | 1986-02-20 | Kenji Suzuki | トリペプチドアミド類 |
| EP0755942B1 (fr) * | 1994-03-11 | 1999-08-04 | Daiichi Pharmaceutical Co., Ltd. | Derive type n-amidino de dermorphin |
| RU2067000C1 (ru) * | 1994-06-29 | 1996-09-27 | Владислав Исакович Дейгин | Пептид и способ его получения |
-
1996
- 1996-09-10 WO PCT/JP1996/002572 patent/WO1997010261A1/fr not_active Application Discontinuation
- 1996-09-10 US US09/029,604 patent/US6228841B1/en not_active Expired - Fee Related
- 1996-09-10 BR BR9610086-9A patent/BR9610086A/pt not_active Application Discontinuation
- 1996-09-10 CA CA002231174A patent/CA2231174A1/fr not_active Abandoned
- 1996-09-10 EP EP96929575A patent/EP0861849A4/fr not_active Withdrawn
- 1996-09-10 AU AU68905/96A patent/AU718192B2/en not_active Ceased
- 1996-09-10 CN CN96197962A patent/CN1200736A/zh active Pending
- 1996-09-10 EA EA199800287A patent/EA001000B1/ru not_active IP Right Cessation
- 1996-09-10 KR KR1019980701802A patent/KR19990044553A/ko not_active Application Discontinuation
-
1998
- 1998-03-10 NO NO981051A patent/NO981051L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9610086A (pt) | 1999-12-21 |
| EA199800287A1 (ru) | 1998-08-27 |
| AU6890596A (en) | 1997-04-01 |
| EP0861849A1 (fr) | 1998-09-02 |
| NO981051D0 (no) | 1998-03-10 |
| AU718192B2 (en) | 2000-04-06 |
| CN1200736A (zh) | 1998-12-02 |
| EA001000B1 (ru) | 2000-08-28 |
| KR19990044553A (ko) | 1999-06-25 |
| WO1997010261A1 (fr) | 1997-03-20 |
| EP0861849A4 (fr) | 1999-05-26 |
| CA2231174A1 (fr) | 1997-03-20 |
| US6228841B1 (en) | 2001-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9605270A (es) | Amidas de acidos tiocarboxilicos aromaticas substituidas. | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| DE59308619D1 (de) | Germicide wirkstoffkombinationen | |
| HUP0002495A1 (hu) | VLA-4 Által közvetített leukocita adhéziót gátló dipeptidszármazékok és rokon vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| MX9706069A (es) | Nuevos inhibidores de la trombina. | |
| CA2256582A1 (fr) | Acides oxa et composes apparentes utilises dans le traitement d'etats dermatologiques | |
| ES2191412T3 (es) | Derivados de aminoacidos que contienen fluor. | |
| DE68914292T2 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| MX9503529A (es) | Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen. | |
| ES2133324T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso. | |
| EP1140900A4 (fr) | Composes pyrazole et utilisation de tels composes | |
| ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| DE69636987D1 (de) | Mittel zur förderung von knochenbildung | |
| ATE181731T1 (de) | Isothioharnstoff-derivate als no synthase hemmer | |
| ATE148741T1 (de) | Reinigendes desinfektionsmittel | |
| NO981051L (no) | Peptidderivater | |
| DE69420310T2 (de) | Substituierte Pyrrole | |
| MX9303587A (es) | Producto para el cuidado de lentes de contacto, para lentes de contacto duros o blandos. | |
| EA200200807A1 (ru) | Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece | |
| EA200001107A1 (ru) | ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ | |
| NO981052L (no) | Peptidderivater | |
| NO984206L (no) | Fremgangsmaate for fremstilling av N-beskyttende D-prolinderivater | |
| NO955224L (no) | N-cyanometylerte kitosaner og hydrolysater derav | |
| NO973341L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse | |
| AU557068B2 (en) | 1-aroyl-5-oxo-2-pyrrolidine propanoic acids and esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |